Abstract:Background African American (AA) kidney transplant recipients exhibit a higher rate of graft loss compared to other racial and ethnic populations, highlighting the need to identify causative factors underlying this disparity. Method We analyzed RNA sequences of pretransplant whole blood from subjects followed in three kidney transplant cohorts to identify single nucleotide polymorphisms (SNPs) associated with death censored graft loss (DCGL). We employed a meta-analysis to uncover key transcriptional signatures and pathways associated with the identified SNPs and used single cell RNA to define cellular specificity. We characterized SNP functions using in vitro immunological and survival assays and tested for associations between the identified SNPs and other immune-related diseases using a ∼30,100 subject, electronic health record (EHR)-linked database. Results We uncovered a cluster of four consecutive missense SNPs in the Leukocyte Immunoglobulin-Like Receptor B3 ( LILRB3 , a negative immune response regulator) gene that strongly associated with DCGL. This LILRB3 -4SNPs cluster encodes missense mutations at amino acids 617-618 proximal to a SHP-1/2 phosphatase-binding ITIM motif. LILRB3 -4SNPs is specifically enriched within subjects of AA ancestry (8.6% prevalence vs 2.3% in Hispanic and 0.1% in European populations), is not linked to APOL1 G1/G2 alleles, and exhibited a strong association with DCGL. Analysis of PBMC and transplant biopsies from recipients with LILRB3 -4SNPs showed evidence of enhanced adaptive immune responsiveness and ferroptosis-associated death in monocytes. Overexpression of the variant allele in THP-1 cells (macrophage line) induced augmented inflammation and ferroptosis, which were attenuated by a ferroptosis inhibitor, verifying a causal link. The LILRB3 -4SNPs also associated with multiple systemic and organ-specific immune-related diseases in AAs, consistent with conferring a broadly relevant immune function. Conclusion the LILRB3 -4SNPs represent a functionally important, distinct genetic risk factor for kidney transplant outcome and development/severity of other immune-related diseases in patients of AA ancestry. Pharmacological targeting of ferroptosis should be tested to prevent or treat these disease processes in AA recipients carrying LILRB3 -4SNPs. ### Competing Interest Statement Dr. Zhang reports personal fees from VericiDx and reports the patents (1. Patents US Provisional Patent Application F&R ref 27527-0134P01, Serial No. 61/951,651, filled March 2014. Method for identifying kidney allograft recipients at risk for chronic injury; 2. US Provisional Patent Application: Methods for Diagnosing Risk of Renal Allograft Fibrosis and Rejection (miRNA); 3. US Provisional Patent Application: Method for Diagnosing Subclinical Acute Rejection by RNA sequencing Analysis of a Predictive Gene Set; 4. US Provisional Patent Application: Pretransplant prediction of post-transplant acute rejection.); Dr Menon receives research support from Natera. Dr. Cravedi is a consultant for Chinook therapeutics. Dr. Lorenzo Gallon is the non-executive Director and Chair of the science advisory board for Verici. Other investigators have no financial interest to declare. The genomic data of pre- and post-transplant specimen in this study were posted to NCBI Gene Expression Omnibus database (GSE252274). The RNAseq data from VericiDx Inc. is available upon request.

Association Between a TLR2 Gene Polymorphism (rs3804099) and Proteinuria in Kidney Transplantation Recipients

Polymorphisms in Stat4 Increase the Risk of Acute Renal Allograft Rejection in the Chinese Population

CTLA4 Gene Polymorphisms Influence the Incidence of Infection after Renal Transplantation in Chinese Recipients.

Association of Fc Gamma Receptor IIIB Polymorphism with Renal-Allogrft in Chinese

Role of Toll-Like Receptors Gene Polymorphism in Renal Transplantation

Impacts of Recipient's SNP of Cytokine and Cytokine Receptor on the Incidence of Infection after Renal Transplantation

TLR10 Genotypes Affect Long-Term Graft Function in Tacrolimus-Treated Solid Organ Transplant Recipients.

Influence of TLR4 Rs1927907 Locus Polymorphisms on Tacrolimus Pharmacokinetics in the Early Stage after Liver Transplantation

CTLA4 Polymorphisms and De Novo Malignancy Risk after Renal Transplantation in Chinese Recipients.

Single Nucleotide Polymorphisms of IL-33 Gene Correlated with Renal Allograft Fibrosis in Kidney Transplant Recipients

Genetic association of tumor necrosis factor-β, interleukin-10, and interleukin-1 gene cluster polymorphism with susceptibility to pneumonia in kidney transplant recipients.

Pharmacogenetic analysis of interleukin-10 variants and tacrolimus metabolism in kidney transplant patients from Pakistani population

Genetic polymorphisms of Leukocyte Immunoglobulin-Like Receptor B3 (LILRB3) gene in African American kidney transplant recipients are associated with post-transplant graft failure

Association Between A Gain-Of-Function Variant of Ptpn22 and Rejection in Liver Transplantation

The Impact of ABCC2 -24C>T Gene Polymorphism on Graft Survival in Kidney Transplant Recipients

Effect of leptin concentrations and leptin receptor gene polymorphisms on the outcome of renal transplantation

Analysis of IL-17A, IL-17F, and miR-146a-5p Prior to Transplantation and Their Role in Kidney Transplant Recipients

Genetic Risk Factors for Post-Transplantation Diabetes Mellitus in Chinese Han Renal Allograft Recipients Treated with Tacrolimus.

Association Between Donor And Recipient Interleukin-18 Gene Polymorphisms And The Risk Of Infection After Liver Transplantation

Association between interferon gamma +874 T>A polymorphism and acute renal allograft rejection: evidence from published studies

Correlation of Tumor Necrosis Factor-Β and Interleukin-1 Gene Cluster Polymorphism with Susceptibility to Bacteremia in Patients Undergoing Kidney Transplantation.